BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 312653)

  • 1. Effect of 8-methoxypsoralen plus UVA (PUVA) on lymphocyte transformation and T cells in psoriatic patients.
    Fräki JE; Eskola J; Hopsu-Havu VK
    Br J Dermatol; 1979 May; 100(5):543-50. PubMed ID: 312653
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of 8-methoxypsoralen (8-MOP) and UVA on human lymphocytes.
    Lischka G; Bohnert E; Bächtold G; Jung EG
    Arch Dermatol Res (1975); 1977 Sep; 259(3):293-8. PubMed ID: 911195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photochemotherapy (PUVA) and psoriasis: comparison of 8-MOP and 8-MOP/5-MOP.
    Langner A; Wolska H; Kowalski J; Duralska H; Murawska E
    Int J Dermatol; 1976 Nov; 15(9):688-9. PubMed ID: 977210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of lymphocytes in patients with psoriasis under photochemotherapy. A study of lymphocyte transformation.
    Wassilew SW
    Arch Dermatol Res; 1978 Nov; 263(2):127-34. PubMed ID: 736599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte proliferation during PUVA therapy.
    Lischka G
    Arch Dermatol Res; 1979 Jun; 265(2):213-8. PubMed ID: 464663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dark effect of 8-methoxypsoralen (8-MOP) on lymphocytes.
    Lischka G; Decker E
    Arch Dermatol Res; 1978 May; 261(3):267-72. PubMed ID: 686810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient impairment of peripheral blood lymphocyte function during PUVA therapy.
    Morison WL; Parrish JA; Bloch KJ; Krugler JI
    Br J Dermatol; 1979 Oct; 101(4):391-7. PubMed ID: 315786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of PUVA treatment on circulating lymphocytes.
    Clayton R; Valdimarsson H; Fry L
    Br J Dermatol; 1979 Feb; 100(2):225-6. PubMed ID: 427023
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of resistant psoriasis with oral 8-methoxypsoralen and longwave ultraviolet light (PUVA). A treatment schedule and a follow-up study.
    Weismann K; Howitz J; Bro-Jorgensen A
    Acta Derm Venereol; 1977; 57(1):73-6. PubMed ID: 74173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T lymphocyte E rosette function during photochemotherapy (PUVA) of psoriasis.
    Haftek M; Gliński W; Jabłońska S; Obałek S
    J Invest Dermatol; 1979 May; 72(5):214-8. PubMed ID: 313426
    [No Abstract]   [Full Text] [Related]  

  • 11. [Photochemotherapy of psoriasis using 8-methoxypsoralen and UVA. II. Binding of the photosensitizator to protein].
    Meffert H; Diezel W; Günther W; Sönnichsen N
    Dermatol Monatsschr; 1976 Nov; 162(11):887-92. PubMed ID: 1017521
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experience with photochemotherapy with 8-methoxypsoralene by mouth and long-wave ultraviolet light (PUVA-treatment) in psoriasis].
    Suurmond D; Burger PM; Schothorst AA; Smit AF; van Vloten WA; Polano MK
    Ned Tijdschr Geneeskd; 1978 Jan; 122(3):69-75. PubMed ID: 622199
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experience with the 8-methoxypsoralen-UVA therapy (photochemotherapy) of psoriasis].
    Hofmann C; Plewig G; Braun-Falco O
    Hautarzt; 1976 Dec; 27(12):588-94. PubMed ID: 1010746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-S-cysteinyldopa excretion after treatment with 8-methoxypsoralen and UVA light.
    Agrup G; Hansson C; Rorsman H; Rosengren A-M ; Rosengren E; Tegner E
    J Invest Dermatol; 1978 Jan; 70(1):25-6. PubMed ID: 618976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human peripheral lymphocyte--a model system for studying the combined effect of psoralen plus black light.
    Scherer R; Kern B; Braun-Falco O
    Klin Wochenschr; 1977 Feb; 55(3):137-40. PubMed ID: 834022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of HTLA-positive lymphocytes during oral photochemotherapy of psoriasis.
    Schmitt D; Ortonne JP; Alario A; Thivolet J
    Arch Dermatol Res; 1979 Nov; 266(3):227-231. PubMed ID: 316688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal T-lymphocyte function in psoriatic patients undergoing methoxsalen photochemotherapy.
    Harper RA; Tam DW; Vonderheid EC; Urbach F
    J Invest Dermatol; 1979 Jun; 72(6):323-5. PubMed ID: 312888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled study of PUVA and adjunctive topical therapy in the management of psoriasis.
    Morison WL; Parrish JA; Fitzpatrick TB
    Br J Dermatol; 1978 Feb; 98(2):125-32. PubMed ID: 629867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal lymphocyte function following long-term PUVA therapy for psoriasis.
    Morison WL; Wimberly J; Parrish JA; Bloch KJ
    Br J Dermatol; 1983 Apr; 108(4):445-50. PubMed ID: 6838768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Photochemotherapy of psoriasis with 8-methoxypsoralen and ultraviolet light. I. Radiation equipment].
    Meffert H; Tetsch H; Metz D; Meffert B
    Dermatol Monatsschr; 1976 Aug; 162(8):684-5. PubMed ID: 971786
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.